Related references
Note: Only part of the references are listed.A real-world analysis of factors associated with high healthcare resource utilization and costs in patients with myasthenia gravis receiving second-line treatment
Angela Ting et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2023)
Development of a Long-Term Cross-Sectoral Case and Care Management Manual for Patients With Severe Multiple Sclerosis and Their Caregivers
Anne Mueller et al.
PROFESSIONAL CASE MANAGEMENT (2023)
Interventions to reduce cancer screening inequities: the perspective and role of patients, advocacy groups, and empowerment organizations
Afua Richardson-Parry et al.
INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH (2023)
Understanding the Symptom Burden and Impact of Myasthenia Gravis from the Patient's Perspective: A Qualitative Study
Kristi Jackson et al.
NEUROLOGY AND THERAPY (2023)
Impact of social determinants of health on individuals living with generalized myasthenia gravis and implications for patient support programs
Tom Hughes et al.
FRONTIERS IN PUBLIC HEALTH (2023)
Real world study on prevalence, treatment and economic burden of myasthenia gravis in Italy
Giovanni Antonini et al.
HELIYON (2023)
Social Needs Resource Connections: A Systematic Review of Barriers, Facilitators, and Evaluation
Anna Louise Steeves-Reece et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2022)
Burden of disease in myasthenia gravis: taking the patient's perspective
Sophie Lehnerer et al.
JOURNAL OF NEUROLOGY (2022)
Communication, Coordination, and Security for People with Multiple Sclerosis (COCOS-MS): a randomised phase II clinical trial protocol
Heidrun Golla et al.
BMJ OPEN (2022)
Real-World Healthcare Resource Utilization and Cost Burden Assessment for Adults With Generalized Myasthenia Gravis in the United States
Glenn Phillips et al.
FRONTIERS IN NEUROLOGY (2022)
A retrospective longitudinal cohort study of the clinical burden in myasthenia gravis
Linda Harris et al.
BMC NEUROLOGY (2022)
The role of advocacy and empowerment in shaping service development for families raising children with developmental disabilities
Zsofia Szlamka et al.
HEALTH EXPECTATIONS (2022)
The humanistic burden of myasthenia gravis: A systematic literature review
Deborah Gelinas et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2022)
Stroke Care Costs and Cost-Effectiveness to Inform Health Policy
Janet Prvu Bettger et al.
STROKE (2022)
Current Treatment of Myasthenia Gravis
Mohammed K. Alhaidar et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Socio-Economic Burden of Myasthenia Gravis: A Cost-of-Illness Study in Bulgaria
Valentina Ignatova et al.
FRONTIERS IN PUBLIC HEALTH (2022)
Underrepresented Voices: Impacts of Social Determinants of Health on Type 1 Diabetes Family Management in Single-Parent, Black Families
Jennifer F. Morone et al.
CANADIAN JOURNAL OF DIABETES (2022)
Role of complement, anti-complement therapeutics, and other targeted immunotherapies in myasthenia gravis
Marinos C. Dalakas
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2022)
Unfavorable social determinants of health are associated with higher burden of financial toxicity among patients with atherosclerotic cardiovascular disease in the US: findings from the National Health Interview Survey
Javier Valero-Elizondo et al.
ARCHIVES OF PUBLIC HEALTH (2022)
Cost-effectiveness of Case Management: A Systematic Review
Ann-Kathrin Klaehn et al.
AMERICAN JOURNAL OF MANAGED CARE (2022)
Social, professional and neuropsychiatric outcomes in patients with myasthenia gravis
Bruno Kusznir Vitturi et al.
NEUROLOGICAL SCIENCES (2021)
Research with youth of color in low-income communities: Strategies for recruiting and retaining participants
Tamar Mendelson et al.
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY (2021)
The Cost of Implementing and Sustaining the COMprehensive Post-Acute Stroke Services Model
William S. Bayliss et al.
MEDICAL CARE (2021)
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT) : a multicentre, randomised, placebo-controlled, phase 3 trial
James F. Jr Jr Howard et al.
LANCET NEUROLOGY (2021)
Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations
Laura Dresser et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Living Well with Kidney Disease by Patient and Care-Partner Empowerment: Kidney Health for Everyone Everywhere
Kamyar Kalantar-Zadeh et al.
NEPHRON (2021)
Social Determinants of Health and Diabetes: A Scientific Review
Felicia Hill-Briggs et al.
DIABETES CARE (2021)
A study of comorbidities in myasthenia gravis
Usha K. Misra et al.
ACTA NEUROLOGICA BELGICA (2020)
Effect of Sugammadex on Postoperative Myasthenic Crisis in Myasthenia Gravis Patients: Propensity Score Analysis of a Japanese Nationwide Database
Hideyuki Mouri et al.
ANESTHESIA AND ANALGESIA (2020)
Burden and impact of takotsubo syndrome in myasthenic crisis: A national inpatient perspective on the under-recognized but potentially fatal association
Rupak Desai et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)
Employment in Myasthenia Gravis: A Systematic Literature Review and Meta-Analysis
Erika Guastafierro et al.
NEUROEPIDEMIOLOGY (2020)
Out-of-pocket expenses for myasthenia gravis patients in China: a study on patients insured by basic medical insurance in China, 2013-2015
Tao-yu Lin et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
Economic Costs of Myasthenia Gravis: A Systematic Review
Eri Landfeldt et al.
PHARMACOECONOMICS (2020)
Progress in the therapy of myasthenia gravis: getting closer to effective targeted immunotherapies
Marinos C. Dalakas
CURRENT OPINION IN NEUROLOGY (2020)
Incidence, mortality, and economic burden of myasthenia gravis in China: A nationwide population-based study
Jingshan Chen et al.
LANCET REGIONAL HEALTH-WESTERN PACIFIC (2020)
A Review of Psychiatric Comorbidity in Myasthenia Gravis
Christina Law et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2020)
Employment in refractory myasthenia gravis: A Myasthenia Gravis Foundation of America Registry analysis
Linda Harris et al.
MUSCLE & NERVE (2019)
Cross-sectional analysis of the Myasthenia Gravis Patient Registry: Disability and treatment
Gary Cutter et al.
MUSCLE & NERVE (2019)
Understanding the burden of refractory myasthenia gravis
Christiane Schneider-Gold et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2019)
Case Management in Primary Care for Frequent Users of Health Care Services: A Mixed Methods Study
Catherine Hudon et al.
ANNALS OF FAMILY MEDICINE (2018)
Association of a Care Coordination Model With Health Care Costs and Utilization The Johns Hopkins Community Health Partnership (J-CHiP)
Scott A. Berkowitz et al.
JAMA NETWORK OPEN (2018)
Direct and indirect cost of myasthenia gravis: A prospective study from a tertiary care teaching hospital in India
Kamlesh Kumar Sonkar et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2017)
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
James F. Howard et al.
LANCET NEUROLOGY (2017)
Inpatient cost analysis for treatment of myasthenia gravis
Jacklyn O. Omorodion et al.
MUSCLE & NERVE (2017)
Social disadvantages associated with myasthenia gravis and its treatment: a multicentre cross-sectional study
Yuriko Nagane et al.
BMJ OPEN (2017)
COST-MINIMIZATION ANALYSIS COMPARING INTRAVENOUS IMMUNOGLOBULIN WITH PLASMA EXCHANGE IN THE MANAGEMENT OF PATIENTS WITH MYASTHENIA GRAVIS
Julio C. Furlan et al.
MUSCLE & NERVE (2016)
Labour market participation and sick leave among patients diagnosed with myasthenia gravis in Denmark 1997-2011: a Danish nationwide cohort study
Asger Frost et al.
BMC NEUROLOGY (2016)
Reducing Readmissions After Stroke With a Structured Nurse Practitioner/Registered Nurse Transitional Stroke Program
Christina Condon et al.
STROKE (2016)
Clinical features and impact of myasthenia gravis disease in Australian patients
Stefan Blum et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2015)
Outcomes of a Quality Improvement Project Implementing Stroke Discharge Advocacy to Reduce 30-Day Readmission Rates
Kristen M. Poston et al.
JOURNAL OF NURSING CARE QUALITY (2014)
Estimated cost of treating myasthenia gravis in an insured U.S. population
Jeffery T. Guptill et al.
MUSCLE & NERVE (2012)
COST ANALYSIS OF MYASTHENIA GRAVIS FROM A LARGE U.S. INSURANCE DATABASE
Jeffrey T. Guptill et al.
MUSCLE & NERVE (2011)
Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy
Karsten Schepelmann et al.
JOURNAL OF NEUROLOGY (2010)
Nationwide Population-Based Epidemiological Study of Myasthenia Gravis in Taiwan
Chien-Hsu Lai et al.
NEUROEPIDEMIOLOGY (2010)
The Impact of a Proactive Chronic Care Management Program on Hospital Admission Rates in a German Health Insurance Society
Brent Hamar et al.
POPULATION HEALTH MANAGEMENT (2010)